Crucell, Merck, Sanofi-Aventis S.A. deal

CRXL granted Merial Ltd. (London, U.K.), a JV between SAN and MRK, a license to use CRXL's PER.C6 technology to develop and commercialize vaccines for foot-and-mouth disease (FMD). CRXL receives an up...